The market is dominated by domestic suppliers, as imports account for 34.1% of total market size in 2024. B2B drives market demand, with B2B spending representing 88.6% of total demand in 2024. Japan has the second largest market size for pharmaceuticals regionally, with demand reaching USD107 billion in 2024. Chugai Pharmaceutical Co Ltd is the largest company in Japan, generating 9.8% of the industry’s total production value in 2024. The industry is fragmented, with the top five companies generating 38.7% of total production value in 2024. The total number of companies increases in 2024, to 914 units. The costs of the industry decrease by 5.1% in 2024, largely driven by declining B2B costs. The industry’s profitability decreases and stands at 9.5% of production value in 2024, the 19th highest regionally. The industry’s exports share increases in 2024 to 6.7% of total production output. With production value of USD59.6 billion, Japan accounts for 9.0% of the Asia Pacific total in 2024.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF.
Overview:
This Euromonitor industrial report provides unique information on Pharmaceuticals in Japan: ISIC 2423. With this industrial report, you’ll be able to explore the industry from its sources of supply to its buyers. The Pharmaceuticals in Japan: ISIC 2423 report includes: Industry datagraphics including production data, exports, imports, cost structure, and profitability
The Pharmaceuticals and Medical Equipment in Japan report includes:
- Five year forecasts on industry’s historic trends and growth
- Insights on key factors shaping industry’s historic and future performance
- Historic data on industry’s turnover, market size, imports and exports
- Detailed overview of industry’s supply and demand structure
- Analysis of competitive landscape changes within the industry
This report answers:
- What is the turnover of the Pharmaceuticals and Medical Equipment?
- How the Pharmaceuticals and Medical Equipment will perform in the future?
- Which categories are driving industry's growth?
- Which factors will shape industry’s performance?
- What is the industry’s costs and demand structure?
- How profitable is the industry?
- Is industry’s competitive landscape concentrated or fragmented?
Pharmaceuticals in Japan: ISIC 2423
HEADLINES
MARKET OVERVIEW
Pharmaceuticals and Medical Equipment
Pharmaceuticals and Medical Equipment is an aggregation of Pharmaceuticals, Medical and Surgical Equipment.
See all of our definitionsBuy this report to:
- Understand future opportunities and threats within the industry
- Track demand and supply structure
- Understand competitive landscape of the industry
- Inform market, strategy development and supply functions
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!